Human parvoviruses: implications for transfusion medicine
- 1 September 1994
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 34 (9), 821-827
- https://doi.org/10.1046/j.1537-2995.1994.34994378286.x
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Human parvovirus B19-associatedarthritis in childrenThe Journal of Pediatrics, 1993
- Two anti-parvovirus B 19 IgM capture assays incorporating a mouse monoclonal antibody specific for B 19 viral capsid proteins VP 1 and VP 2Archiv für die gesamte Virusforschung, 1992
- Removal of parvovirus B19 from contaminated factor VIII during fractionationJournal of Medical Virology, 1991
- Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 1990
- Manifestations and treatment of human parvovirus B19 infection in immunocompromised patientsThe Journal of Pediatrics, 1990
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989
- Human Parvo Virus B19 Infection among Hospital Staff Members after Contact with Infected PatientsNew England Journal of Medicine, 1989
- Chronic Bone Marrow Failure Due to Persistent B19 Parvovirus InfectionNew England Journal of Medicine, 1987
- Human parvovirus associated with erythroblastopenia in iron deficiency anaemia.Journal of Clinical Pathology, 1986
- TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 1983